A STANDARD HEPARIN NOMOGRAM FOR THE MANAGEMENT OF HEPARIN-THERAPY

被引:258
作者
CRUICKSHANK, MK
LEVINE, MN
HIRSH, J
ROBERTS, R
SIGUENZA, M
机构
[1] HAMILTON CIV HOSP, RES CTR, HAMILTON, ONTARIO, CANADA
[2] MCMASTER UNIV, DEPT CLIN EPIDEMIOL & BIOSTAT, HAMILTON L8S 4L8, ONTARIO, CANADA
关键词
D O I
10.1001/archinte.151.2.333
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A nomogram for the adjustment of heparin dosage was developed to standardize heparin therapy and to reduce delays in achieving and maintaining a therapeutic activated partial thromboplastin time (APTT) result. Fifty consecutive patients with acute venous thromboembolism had their continuous intravenous heparin therapy adjusted according to this heparin nomogram. The effect of the nomogram on heparin therapy in these patients was compared with data from 53 historical control patients. The proportion of patients in the nomogram group who reached a therapeutic APTT at 24 hours after the start of heparin therapy was 66%, which increased to 81% at 48 hours. In contrast, 37% and 58% of the control patients reached a therapeutic APTT at 24 and 48 hours, respectively. The percentage of therapeutic APTT results of the total number of APTT determinations was greater in the nomogram patients than controls. The use of this heparin nomogram resulted in (1) achieving a therapeutic APTT at 24 and 48 hours in a large proportion of patients and (2) reduced periods of inadequate anticoagulation and overanticoagulation during heparin therapy.
引用
收藏
页码:333 / 337
页数:5
相关论文
共 12 条
[1]   PROSPECTIVE STUDY OF VALUE OF MONITORING HEPARIN TREATMENT WITH ACTIVATED PARTIAL THROMBOPLASTIN TIME [J].
BASU, D ;
CADE, J ;
GALLUS, A ;
HIRSH, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (07) :324-+
[2]  
CHIU HM, 1977, BLOOD, V49, P171
[3]   NON-BIOLOGICAL FACTORS IN DAY TO DAY VARIATION OF HEPARIN REQUIREMENTS [J].
FENNERTY, AG ;
LEVINE, MN .
BRITISH MEDICAL JOURNAL, 1989, 299 (6706) :1012-1013
[4]   AUDIT OF CONTROL OF HEPARIN TREATMENT [J].
FENNERTY, AG ;
THOMAS, P ;
BACKHOUSE, G ;
BENTLEY, P ;
CAMPBELL, IA ;
ROUTLEDGE, PA .
BRITISH MEDICAL JOURNAL, 1985, 290 (6461) :27-28
[5]  
Fleiss JL, 1981, STATISTICAL METHODS, P19
[6]   HEPARIN KINETICS IN VENOUS THROMBOSIS AND PULMONARY-EMBOLISM [J].
HIRSH, J ;
VANAKEN, WG ;
GALLUS, AS ;
DOLLERY, CT ;
CADE, JF ;
YUNG, WL .
CIRCULATION, 1976, 53 (04) :691-695
[7]   CONTINUOUS INTRAVENOUS HEPARIN COMPARED WITH INTERMITTENT SUBCUTANEOUS HEPARIN IN THE INITIAL TREATMENT OF PROXIMAL-VEIN THROMBOSIS [J].
HULL, RD ;
RASKOB, GE ;
HIRSH, J ;
JAY, RM ;
LECLERC, JR ;
GEERTS, WH ;
ROSENBLOOM, D ;
SACKETT, DL ;
ANDERSON, C ;
HARRISON, L ;
GENT, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (18) :1109-1114
[8]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481
[9]   HEMORRHAGIC COMPLICATIONS OF ANTICOAGULANT-THERAPY [J].
LEVINE, MN ;
HIRSH, J .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1986, 12 (01) :39-57
[10]  
MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163